<unk>  is prevented by withholding prescription to pregnant women or those trying to conceive. As<unk>  can remain in the mother’s body for up to five days,<unk>  should not be administered in the days leading up to conception. Doctors must take care to ensure women of reproductive age are aware of the risks to the baby should they get pregnant, before prescribing<unk> . For some women, such as those with prosthetic heart valves, anticoagulation medication cannot be suspended during pregnancy as the risk of thrombus and emboli is too high. In such cases an alternate anticoagulant, which cannot pass through the placental barrier to the fetus, is proscribed in place of<unk> . Heparin is one such anticoagulant medication, although its efficacy in patients with prosthetic heart valves is not well established. New anticoagulant medications, which are efficacious and non-teratogenic such as ximelagatran continue to be developed.
Fetal warfarin syndrome
Neonatal sepsis
Fetal hydantoin syndrome
Shaken baby syndrome
Neonatal stroke
Fetal trimethadione syndrome
Neonatal meningitis
Uremic fetor